Drug Profile
Research programme: ribosomal S6 kinase inhibitors - Luna Innovations
Alternative Names: RSK inhibitors - Luna InnovationsLatest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator University of Virginia
- Developer Luna Innovations
- Class
- Mechanism of Action Ribosomal protein S6 kinase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Infections
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Infections in USA
- 20 Jun 2008 Preclinical trials in Infections in USA (unspecified route)